Cincinnati Sub-Zero - Blanketrol III
by Cincinnati Sub-Zero

Follow Us

Blanketrol III total body Hyper-Hypothermia water therapy system provides effective patient warming and/or cooling all in one system.

The Blanketrol III offers the same large heater and highest flow rates as the Blanketrol II, but it has added features that make it the most innovative of any hyper-hypothermia system providing a fast response to core body temperature regulation.

FORUMSView All (12)
Ask a New Question


2 months ago
Snap Disc Remove from service

Has anyone got an error code EE0.2 Snap Disc Remove from service. Any suggestions if you have?



a year ago
Threaded barb to flow switch - Part#??

Hey guys, 

I'm looking to order a replacement threaded to barb nylon fitting for Blanketrol III, the one that goes from the out on the flow switch. Does anyone know where I can order one? 

Equipment: Cincinnati Sub-Zero - Blanketrol III



-Tamara Anderson
3 years ago
Protective layer between blanket and patient
Can a layer be placed between the maxitherm light blanket (such as a chux or a blanket) and the infant?Reply
SERVICE COMPANIESView All Warming/Cooling Unit Companies


  • Preset-Variable and Programmable Variable Gradient temperature selection is available in both heating and cooling mode which allows for rapid or gradual patient temperature management control.   
  • A new feature, SMART mode, associated with the term gradient setting is to have the ability for the BIII to adjust the gradient temperature settings of 5°C should you not reach your desired patient temperature within 30 minutes. The Blanketrol III continues to monitor and adjust temperature every 30 minutes until your desired patient temperature is reached.          


Height37.5 in
Length 17 in
Weight122 lbs
Width17 in

Additional Specifications

Fluid Temperature Range: 4°C to 42°C (39.2°F to 107.6°F)          Patient Temperature Set Point Range: 30°C to 40°C (86°-104°F)          Flow Rate 32 gph (121.1 lph) with blanket, approx.>

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Please review our Privacy Policy for more details.
I Agree